Drug details:
Molecular formula: C₂₉H₁₈N₂O₄

Standard name: 2-[4-[3-(furan-2-yl)-5-phenyl-1,2-oxazol-4-yl]phenyl]quinoline-4-carboxylic acid

Curated SMILES: O=C(O)C1=CC(C2=CC=C(C3=C(C4=CC=CC=C4)ON=C3C3=CC=CO3)C=C2)=NC2=CC=CC=C21

Evidence for compound's anti-virulence activity:

Escherichia
Related VF: TTSS (Type III secretion system)
Target: NleB1
Drug effect: Inhibits the activity of Escherichia coli NleB1.
Max phase: Preclinical (in vitro)
Publication:
El Qaidi S, et al., 2018. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors. Front Cell Infect Microbiol 8:435.

Salmonella
Related VF: TTSS (SPI-2 encode)
Target: SseK1/SseK2
Drug effect: Inhibits SseK1/SseK2 Arg glycosyltransferase activity.
Max phase: Preclinical (in vitro)
Publication:
El Qaidi S, et al., 2018. High-Throughput Screening for Bacterial Glycosyltransferase Inhibitors. Front Cell Infect Microbiol 8:435.